The new $467 million includes $400 million in royalties for the Pfizer-BioNTech vaccine from 2020 through 2023.
Penn has reached an agreement to resolve a dispute over Covid-19 royalties the Philadelphia university alleged it was owed.
In a regulatory filing, BioNTech (BNTX) said, “BioNTech previously disclosed that it was in discussions with the University ...
Morgan Stanley analyst Terence Flynn notes that BioNTech (BNTX) announced last week that it had reached a settlement agreement with the National Institutes of Health and University of Pennsylvania ...
Bengaluru: German biotechnology company BioNTech has reached two separate settlement agreements with the U.S. National ...
Stocktwits on MSN5d
BioNTech Stock In Focus After $791.5M Settlement With NIH: Retail CautiousShares of BioNTech slipped 0.83% in after-hours trading on Friday after the company said it would pay $791.5 million in a ...
BioNTech has come to a settlement with both NIH and the University of Pennsylvania, by which the German pharma firm had ...
Morgan Stanley analyst Terence Flynn notes that BioNTech (BNTX) announced last week that it had reached a settlement agreement with the National Institutes of Health and University of Pennsylvania ...
Recent health developments include a new injectable cancer drug by Bristol Myers Squibb, a revived lawsuit against Novartis ...
Recent developments in health include the FDA approving an injectable version of Opdivo, a revived lawsuit against Novartis ...
German company BioNTech has entered into two separate settlement agreements with the US federal agency for medical research and the University of Pennsylvania over the payment of royalties related to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback